sulpiride has been researched along with Movement Disorders in 16 studies
Sulpiride: A dopamine D2-receptor antagonist. It has been used therapeutically as an antidepressant, antipsychotic, and as a digestive aid. (From Merck Index, 11th ed)
sulpiride : A member of the class of benzamides obtained from formal condensation between the carboxy group of 2-methoxy-5-sulfamoylbenzoic acid and the primary amino group of (1-ethylpyrrolidin-2-yl)methylamine.
Movement Disorders: Syndromes which feature DYSKINESIAS as a cardinal manifestation of the disease process. Included in this category are degenerative, hereditary, post-infectious, medication-induced, post-inflammatory, and post-traumatic conditions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We compared the efficacy of ziprasidone and amisulpride in the treatment of negative symptoms and overall psychopathology in subjects who had chronic schizophrenia with predominantly negative symptoms." | 9.12 | Ziprasidone and amisulpride effectively treat negative symptoms of schizophrenia: results of a 12-week, double-blind study. ( Murray, S; Olié, JP; Spina, E; Yang, R, 2006) |
| " This study compared 800 mg/day amisulpride and 20 mg/day haloperidol in patients with acute exacerbations of schizophrenia." | 9.08 | Improvement of acute exacerbations of schizophrenia with amisulpride: a comparison with haloperidol. PROD-ASLP Study Group. ( Boyer, P; Fleurot, O; Möller, HJ; Rein, W, 1997) |
| "Levosulpiride is a newer prokinetic agent with increasingly extensive use in India by general physicians." | 5.48 | Levosulpiride-Induced Dystonia: 7 Cases. ( Goyal, V; Radhakrishnan, DM, 2018) |
| "Levosulpiride is a substituted benzamide that is widely used for the management of dyspepsia and emesis." | 5.35 | Levosulpiride-induced movement disorders. ( Chung, SJ; Kim, JS; Kim, MJ; Lee, MC; Shin, HW, 2009) |
| "We compared the efficacy of ziprasidone and amisulpride in the treatment of negative symptoms and overall psychopathology in subjects who had chronic schizophrenia with predominantly negative symptoms." | 5.12 | Ziprasidone and amisulpride effectively treat negative symptoms of schizophrenia: results of a 12-week, double-blind study. ( Murray, S; Olié, JP; Spina, E; Yang, R, 2006) |
| " This study compared 800 mg/day amisulpride and 20 mg/day haloperidol in patients with acute exacerbations of schizophrenia." | 5.08 | Improvement of acute exacerbations of schizophrenia with amisulpride: a comparison with haloperidol. PROD-ASLP Study Group. ( Boyer, P; Fleurot, O; Möller, HJ; Rein, W, 1997) |
| "Levosulpiride is a newer prokinetic agent with increasingly extensive use in India by general physicians." | 1.48 | Levosulpiride-Induced Dystonia: 7 Cases. ( Goyal, V; Radhakrishnan, DM, 2018) |
| "Five haloperidol-treated animals developed mild TD movements, and no TD was observed in the clozapine group." | 1.40 | Upregulation of dopamine D3, not D2, receptors correlates with tardive dyskinesia in a primate model. ( Blanchet, PJ; Lévesque, D; Mahmoudi, S, 2014) |
| "Aripiprazole treatment at 3 mg/day improved tardive oromandibular dystonia without worsening Parkinsonism." | 1.37 | Efficacy of aripiprazole in sulpiride-induced tardive oromandibular dystonia. ( Ikawa, M; Imai, N, 2011) |
| "Levosulpiride is a substituted benzamide that is widely used for the management of dyspepsia and emesis." | 1.35 | Levosulpiride-induced movement disorders. ( Chung, SJ; Kim, JS; Kim, MJ; Lee, MC; Shin, HW, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (31.25) | 18.7374 |
| 1990's | 5 (31.25) | 18.2507 |
| 2000's | 3 (18.75) | 29.6817 |
| 2010's | 3 (18.75) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Radhakrishnan, DM | 1 |
| Goyal, V | 1 |
| Mahmoudi, S | 1 |
| Lévesque, D | 1 |
| Blanchet, PJ | 1 |
| Shin, HW | 1 |
| Kim, MJ | 1 |
| Kim, JS | 1 |
| Lee, MC | 1 |
| Chung, SJ | 1 |
| Imai, N | 1 |
| Ikawa, M | 1 |
| Kovoor, A | 1 |
| Seyffarth, P | 1 |
| Ebert, J | 1 |
| Barghshoon, S | 1 |
| Chen, CK | 1 |
| Schwarz, S | 1 |
| Axelrod, JD | 1 |
| Cheyette, BN | 1 |
| Simon, MI | 1 |
| Lester, HA | 1 |
| Schwarz, J | 1 |
| Olié, JP | 1 |
| Spina, E | 1 |
| Murray, S | 1 |
| Yang, R | 1 |
| Hanaoka, Y | 2 |
| Ohi, T | 2 |
| Matsukura, S | 2 |
| Nakamura, S | 1 |
| Akiguchi, I | 1 |
| Möller, HJ | 1 |
| Boyer, P | 1 |
| Fleurot, O | 1 |
| Rein, W | 1 |
| Rezayat, M | 1 |
| Azizi, N | 1 |
| Zarrindast, MR | 1 |
| Jenner, P | 1 |
| Marsden, CD | 1 |
| Yamamoto, K | 1 |
| Noda, S | 1 |
| Umezaki, H | 1 |
| Wroe, S | 1 |
| Richens, A | 1 |
| Compston, A | 1 |
| Chouza, C | 1 |
| Caamano, JL | 1 |
| Romero, S | 1 |
| Lorenzo, J | 1 |
| Feres, S | 1 |
| Horikawa, H | 1 |
| Konagaya, M | 1 |
| Mano, Y | 1 |
| Takayanagi, T | 1 |
3 reviews available for sulpiride and Movement Disorders
| Article | Year |
|---|---|
[Ballism, hemiballism].
Topics: Cerebrovascular Disorders; Chlorpromazine; Electromyography; Haloperidol; Humans; Movement Disorders | 1993 |
[Oral dyskinesis, facial dystonia].
Topics: Dyskinesia, Drug-Induced; Dystonia; Face; Female; Humans; Levodopa; Male; Meige Syndrome; Mouth; Mov | 1993 |
The substituted benzamides--a novel class of dopamine antagonists.
Topics: Animals; Antiemetics; Antipsychotic Agents; Behavior, Animal; Benzamides; Brain; Dopamine; Dopamine | 1979 |
2 trials available for sulpiride and Movement Disorders
| Article | Year |
|---|---|
Ziprasidone and amisulpride effectively treat negative symptoms of schizophrenia: results of a 12-week, double-blind study.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Amisulpride; Antipsychotic Agents; Behavioral Sympto | 2006 |
Improvement of acute exacerbations of schizophrenia with amisulpride: a comparison with haloperidol. PROD-ASLP Study Group.
Topics: Adult; Akathisia, Drug-Induced; Amisulpride; Antipsychotic Agents; Brief Psychiatric Rating Scale; D | 1997 |
11 other studies available for sulpiride and Movement Disorders
| Article | Year |
|---|---|
Levosulpiride-Induced Dystonia: 7 Cases.
Topics: Antidepressive Agents, Second-Generation; Dystonia; Humans; India; Movement Disorders; Sulpiride | 2018 |
Upregulation of dopamine D3, not D2, receptors correlates with tardive dyskinesia in a primate model.
Topics: Animals; Antipsychotic Agents; Brain; Cebus; Clozapine; Disease Models, Animal; Dopamine Antagonists | 2014 |
Levosulpiride-induced movement disorders.
Topics: Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Brain; Female; Humans; Magnetic Resonance Imag | 2009 |
Efficacy of aripiprazole in sulpiride-induced tardive oromandibular dystonia.
Topics: Aged, 80 and over; Aripiprazole; Dyskinesia, Drug-Induced; Female; Humans; Jaw; Movement Disorders; | 2011 |
D2 dopamine receptors colocalize regulator of G-protein signaling 9-2 (RGS9-2) via the RGS9 DEP domain, and RGS9 knock-out mice develop dyskinesias associated with dopamine pathways.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antiparkinson Agents; Antipsych | 2005 |
On the mechanism(s) of cholecystokinin (CCK): receptor stimulation attenuates morphine dependence in mice.
Topics: Adrenergic Antagonists; Animals; Atropine; Benzazepines; Ceruletide; Dopamine Antagonists; Male; Met | 1997 |
[A case of hemiballism successfully treated by sulpiride, caused by lesions of the striatum].
Topics: Aged; Aged, 80 and over; Cerebral Infarction; Corpus Striatum; Humans; Magnetic Resonance Imaging; M | 1990 |
[Parkinson's disease associated with trihexyphenidyl (THP) induced dysphonia plicae ventricularis].
Topics: Aged; Female; Humans; Movement Disorders; Parkinson Disease; Sulpiride; Tongue Diseases; Trihexyphen | 1988 |
Bilateral ballistic movements occurring as a late complication of hemispherectomy and responding to sulpiride.
Topics: Adult; Humans; Male; Movement Disorders; Postoperative Complications; Sulpiride; Telencephalon | 1986 |
Extrapyramidal effects of benzamides.
Topics: Basal Ganglia Diseases; Benzamides; Dyskinesia, Drug-Induced; Humans; Metoclopramide; Movement Disor | 1985 |
[Three cases of lingual ballistic movement followed by a rigid-dystonic state of the tongue].
Topics: Aged; Basal Ganglia Diseases; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Male; Movement | 1985 |